DelMar Pharmaceuticals to Present Interim Clinical Data for VAL-083 in Glioblastoma at Society of Neuro-Oncology November 14, 2013 • 8:00 AM EST
DelMar Pharmaceuticals Presents Data Supporting VAL-083 as a Potential Treatment for Three Chemotherapy Resistant Cancers October 21, 2013 • 8:00 AM EDT
DelMar Pharmaceuticals to Present at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Annual Meeting October 15, 2013 • 8:00 AM EDT
DelMar Pharma talks to Life Sciences IP Review (LSIPR) about creating new patents for shelved drugs to streamline path to patients October 9, 2013 • 8:00 AM EDT
DelMar Pharma reviews glioblastoma clinical trials and new therapeutic development on CEOLIVE.TV September 19, 2013 • 8:00 AM EDT
DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com September 16, 2013 • 12:09 PM EDT
DelMar Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com September 12th September 9, 2013 • 8:00 AM EDT
DelMar Pharmaceuticals and Guangxi Wuzhou Pharmaceuticals Establish Clinical Advisory Board in China September 9, 2013 • 8:00 AM EDT
DelMar Pharmaceuticals To Present At The 15th Annual Rodman & Renshaw Global Investment Conference September 3, 2013 • 8:00 AM EDT
DelMar Pharmaceuticals Announces Appointment of Robert J. Toth, Jr. to Board of Directors August 22, 2013 • 8:00 AM EDT